Ji Hyun Sung

Title: Ji Hyun Sung: Innovator in Selective Androgen Receptor Agonists

Introduction

Ji Hyun Sung is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective androgen receptor agonists. His work is aimed at addressing various hormone-related diseases and conditions.

Latest Patents

Ji Hyun Sung holds a patent for an "Oxazolidine-based compound and selective androgen receptor agonist comprising same." This invention provides novel selective androgen receptor agonists, a preparation method thereof, and a pharmaceutical composition that includes these compounds at a pharmaceutically effective amount. The selective androgen receptor agonists developed by Sung act on androgen receptors to increase androgen activity. This innovation is particularly useful as a therapeutic and prophylactic agent for diseases or conditions that may benefit from enhanced androgen receptor activity, including a variety of hormone-related diseases in both males and females, muscle wasting disorders, and osteoporosis.

Career Highlights

Ji Hyun Sung is associated with Dong-a ST Co., Ltd., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the pharmaceutical industry, particularly in the area of hormone-related therapies.

Collaborations

Some of his coworkers include Sung Pil Choi and Seul Min Choi, who contribute to the collaborative efforts within the company.

Conclusion

Ji Hyun Sung's innovative work in the field of selective androgen receptor agonists showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of hormone-related diseases and improve patient outcomes.